450 likes | 776 Vues
بسم الله الرحمن الرحیم. انگلهای مالاریا. Phylum: Apicomplexa Class: Sporozoea Sub-class: Coccidia Order: Eucoccidia Sub-order: Haemosporina Family: Plasmodidae Genus: Plasmodium
E N D
بسم الله الرحمن الرحیم انگلهای مالاریا
Phylum: Apicomplexa • Class: Sporozoea • Sub-class: Coccidia • Order: Eucoccidia • Sub-order: Haemosporina • Family: Plasmodidae • Genus: Plasmodium • Sub-genus: Plasmodium Laverania Vinckeia ….... • Species: vivax falciparum berghei malariae ovale
Characteristic of Sub-genus • 1- Plasmodium • 2- Laverania • 3- Vinckeia
Causal Agents: • There are approximately 156 named species of Plasmodium which infect various species of vertebrates. • Four are known to infect humans: • Blood parasites of the genus Plasmodium. P. falciparum, P. vivax , P. ovale and P. malariae.
Distribution of Malarial Parasites • P. vivax • most widespread, found in most endemic areas including some temperate zones • P. falciparum • primarily tropics and subtropics • P. malariae • similar range as P. falciparum, but less common and patchy distribution • P. ovale • occurs primarily in tropical west Africa
Malaria types • Malignant Tertian Malaria • Agent: P. falciparum • Benign Tertian Malaria • Agent: P. vivax • Benign QuartanMalaria Agent: P. malariae • Benign Tertian Malaria • Agent: P. ovale
Vectores in Iran An. stephenciمهمترین و پایدارترین ناقل در ایران An. superpictus فراگیرترین آنوفل در ایران An. dethaliکوچکترین آنوفل در جنوب شرق ایران An. culicifacies An. fluviatilisخطرناکترین ناقل فالسیپاروم An. maculipennisناقل اصلی درشمال و شمال غرب کشور An. sacharovi ناقل اصلی درشمال و شمال غرب کشور
Life Cycle: Life Cycle
شیوع مالاریا در جهان و ایران • Prevalence rate in the world: > 300,000,000 case • Incidence rate “ “ “ “” “ “ > 100,000,000 case • Mortality rate “ “ “ “ “ “ “ “ 1,000,000 case در سال 1351: 20 هزار مورد در کشور در سال 1362: 20 هزار مورد فقط در استان سیستان و بلوچستان در سال 1377: 40 هزار مورد در استان سیستان و بلوچستان
Malaria Transmission methods • natural (sporozoites/Anopheles) • blood transfusions • shorter incubation period • fatality risk (P. falciparum) • no relapses possible (vivax/ovale) • syringe sharing • congenital • relatively rare although placenta is heavily infected
Clinical features History of exposure: Paroxysm: 1-Chills ( Cold stage) 2-Fever ( Hot stage) 3- Sweating stage Other clinical features: splenomegaly, anemia, thrombocytopenia, hypoglycemia, pulmonary or renal dysfunction, and neurologic changes.
cold stage • feeling of intense cold • vigorous shivering, rigor • lasts 15-60 min
hot stage • intense heat • dry burning skin • throbbing headache • lasts 2-6 hours
sweating stage • profuse sweating • declining temperature • exhausted, weak sleep • lasts 2-4 hours
Malaria Paroxysm • falciparum may not exhi-bit classic paroxysms • continuous fever • 24 hr periodicity tertian malaria quartan malaria
توضیح واژه ها • Relapse • Hypnozoite (Resting stage) • Recrudescence • Induced malaria • Hemozoin
Stippling dots • 1) Schuffner’s dots • 2) Maurer’s dots • 3) Ziemann’s dots • 4) Jame’s dots • Sticky phenomen( knobs)
Malignant Tertian Malaria 1-Cerebral malaria • 2-Black water fever ( severe anemia) • 3-Acute renal failure • 4- Algid malaria • 5- Respiratory distress syndrome (pneumonic malaria) • 6- Gastro-intestinal mlaria • Complications of P. vivax malaria include splenomegaly (with, rarely, splenic rupture), • and those of P. malariae include nephrotic syndrome.
Karunaweera et al (1992) PNAS 89:3200 sweating rigor • TNF = tumor necrosis factor-a () • proinflammatory cytokine (produced in response to malarial antigens?)
Anti-Parasite Immunity • immune response prevents merozoite invasion, eliminates infected erythrocytes, etc. • Anti-Disease Immunity • eg., neutralization of exo-antigens or toxic effects • Immunity • slow to develop • short lived • ‘premunition’ • non-sterilizing • lower parasitemia • less symptoms
Immunity in Malaria • A) Natural immunity • 1-Innate immunity • 2- Genetic immunity B) Acquired immunity • 1-Exo-Erythrocytic stage • Premonition: prevents of super-infection no re-infection (stage specific). 2- Erythrocytic stage concomitant immunity (stage specific & strain specific ): • Ab mediated immunity • Ab dependent cell cytotoxicity (ADCC) • Ab dependent phagocytosis • Cellular immunity
Malaria laboratory diagnosis • 1) Microscopic identification: • -preparing thick and thin biood smear • -comparison of plasmodium species • 2- Quality Buffy Coat ( QBC) • 3) Immunochromatographic methods • 4)Antibody Detection • 5) Molecular diagnosis techniques
Malaria antibody detection The IFA procedure can be used as a diagnostic tool to determine if a patient has been infected with Plasmodium. Blood stage Plasmodium species schizonts (meronts) are used as antigen Enzyme immunoassays have also been employed as a tool to screen blood donors, but are not recommended for clinical diagnosis due to limited sensitivity serologic testing is not practical for routine diagnosis of acute malaria.
Antibody detection may be useful for: 1- screening blood donors 2- testing a patient with a febrile illness who is suspected of having malaria and from whom repeated blood smears are negative ( Fever of Unknown Origin) 3- testing a patient who has been recently treated for malaria but in whom the diagnosis is questioned • Species-specific testing is available for the four human species: P. falciparum, P. vivax, P. malariae, and P. ovale. • Cross reactions often occur between Plasmodium species and Babesia species. .
Rapid Diagnostic Tests(dipstickor test strip) (basedon the detection of antigens malaria parasites; Histiding- rich protein II)
Treatment • Chloroquine • Sulfadoxine-pyrimethamine (Fansidar) • Mefloquine (Lariam) • Quinine • Doxycycline • Artemisin derivatives
Malaria Control • Reduce Human-Mosquito Contact • impregnated bed nets • repellants, protective clothing • screens, house spraying • Reduce Vector • environmental modificaton • larvacides/insecticides • biological control • Reduce Parasite Reservoir • diagnosis and treatment • chemoprophylaxis